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OBJECTIVE—The medial hypothalamus mediates leptin-in-
duced glucose uptake in peripheral tissues, and brain melano-
cortin receptors (MCRs) mediate certain central effects of leptin.
However, the contributions of the leptin receptor and MCRs in
individual medial hypothalamic nuclei to regulation of peripheral
glucose uptake have remained unclear. We examined the effects
of an injection of leptin and the MCR agonist MT-II into medial
hypothalamic nuclei on glucose uptake in peripheral tissues.
RESEARCH DESIGN AND METHODS—Leptin or MT-II was
injected into the ventromedial (VMH), dorsomedial (DMH), ar-
cuate nucleus (ARC), or paraventricular (PVH) hypothalamus or
the lateral ventricle (intracerebroventricularly) in freely moving
mice. The MCR antagonist SHU9119 was injected intracerebrov-
entricularly. Glucose uptake was measured by the 2-[
3H]deoxy-
D-glucose method.
RESULTS—Leptin injection into the VMH increased glucose
uptake in skeletal muscle, brown adipose tissue (BAT), and
heart, whereas that into the ARC increased glucose uptake in
BAT, and that into the DMH or PVH had no effect. SHU9119
abolished these effects of leptin injected into the VMH. Injection
of MT-II either into the VMH or intracerebroventricularly in-
creased glucose uptake in skeletal muscle, BAT, and heart,
whereas that into the PVH increased glucose uptake in BAT, and
that into the DMH or ARC had no effect.
CONCLUSIONS—The VMH mediates leptin- and MT-II–induced
glucose uptake in skeletal muscle, BAT, and heart. These effects
of leptin are dependent on MCR activation. The leptin receptor in
the ARC and MCR in the PVH regulate glucose uptake in BAT.
Medial hypothalamic nuclei thus play distinct roles in leptin- and
MT-II–induced glucose uptake in peripheral tissues. Diabetes
58:2757–2765, 2009
L
eptin is an adipocyte hormone that inhibits food
intake and increases energy expenditure (1). The
hypothalamus is a principal target of leptin in its
regulation of energy metabolism (2–5). The arcu-
ate nucleus (ARC) is the most well characterized of
hypothalamic nuclei in terms of its role in the central
effects of leptin (2–5). The ARC contains two populations of
leptin-responsive neurons: pro-opiomelanocortin (POMC)-
expressing neurons, which release the potent anorexic
peptide -melanocyte–stimulating hormone, and neurons
that release two potent orexigenic peptides, agouti-related
peptide (AgRP) and neuropeptide Y (NPY) (2–5). -Mela-
nocyte–stimulating hormone activates the melanocortin
receptor (MCR), whereas AgRP competitively inhibits this
receptor and NPY functionally antagonizes MCR signaling
(6). Both sets of neurons project to second-order MCR-
expressing neurons within the hypothalamus, including
the paraventricular (PVH), ventromedial (VMH), dorsome-
dial (DMH), and lateral hypothalamus, as well as to other
brain regions such as the brain stem (2,4,7,8). Leptin
inhibits food intake through reciprocal regulation of
POMC and AgRP/NPY neurons in the ARC and consequent
activation of MCR in hypothalamic nuclei, including the
PVH (5,6,7,9). Mice lacking the melanocortin 3 (MC3R) or
4 (MC4R) receptor show increased adiposity and feeding
efﬁciency (4). Restoration of MC4R expression in certain
sets of PVH neurons prevented hyperphagia and reduced
body weight in MC4R-null mice (9). In addition to that in
the ARC, the leptin receptor Ob-Rb in other hypothalamic
nuclei has also been shown to regulate energy intake and
adiposity. Neurons positive for steroidogenic factor 1
(SF1; also known as Ad4BP) (10,11) are largely restricted
to the VMH in the adult brain. Leptin depolarizes these
neurons, and speciﬁc ablation of the leptin receptor in
SF1-positive cells induced obesity and increased suscepti-
bility to a high-fat diet in mice (12).
The leptin receptor in the brain also regulates glucose
metabolism in certain peripheral tissues (13–17). Treat-
ment with leptin ameliorates diabetes in lipodystrophic
mice and humans (18,19). Intravenous or intracerebroven-
tricular administration of leptin markedly increased whole-
body glucose turnover and glucose uptake by certain
tissues in mice without any substantial change in plasma
insulin or glucose levels (13). We have also previously
shown that microinjection of leptin into the medial hypo-
thalamus, such as into the VMH, but not into the lateral
hypothalamus, preferentially increased glucose uptake in
skeletal muscle, heart, and brown adipose tissue (BAT)
(14–16). Restoration of Ob-Rb expression in the ARC and
the VMH of the Ob-Rb–mutated Koletsky rat by adeno-
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improved peripheral insulin sensitivity and reduced
plasma glucose concentration (17,20). Ablation of suppres-
sor of cytokine signaling 3 (SOCS3) in SF1-positive cells
(10,11) improved glucose homeostasis in mice fed a high-
fat diet (21). Furthermore, intracerebroventricular injec-
tion of the MCR agonist (MT-II) increased whole-body
glucose turnover and expression of GLUT4 in skeletal
muscle (22). Ob-Rb in the ARC and the VMH as well as the
brain melanocortin pathway are thus implicated in the
regulation of glucose uptake in peripheral tissues as well
as in energy metabolism. However, little is known about
the contributions of the leptin receptor and MCR in
individual medial hypothalamic nuclei to regulation of
glucose uptake in peripheral tissues, as opposed to their
roles in the regulation of food intake and leanness.
We have now examined the acute effects of microinjec-
tion of leptin and MT-II into the VMH, ARC, DMH, and
PVH, all of which express Ob-Rb, MC3R, and MC4R at a
high level (3–7,23–25), on glucose uptake in peripheral
tissues of mice in vivo. Our results suggest that the VMH
mediates stimulatory actions of leptin and MT-II on glu-
cose uptake in skeletal muscle, heart, and BAT, whereas
the leptin receptor in the ARC as well as MCRs in PVH
regulate glucose uptake in BAT. The medial hypothalamic
nuclei thus appear to play distinct roles in the regulation of
glucose uptake in peripheral tissues by leptin and MT-II.
RESEARCH DESIGN AND METHODS
Male FVB/N Jcl mice (CLEA Japan, Tokyo, Japan) were studied at 12–16
weeks of age. The animals were housed individually in plastic cages at 24 
1°C with lights on from 0600 to 1800 h, and they were maintained with free
access to a laboratory diet (Oriental Yeast, Tokyo, Japan) and water. Mice
were anesthetized by intraperitoneal injection of ketamine (100 mg/kg body
mass) and xylazine (10 mg/kg), and a chronic double-walled stainless steel
cannula was implanted stereotaxically and unilaterally into the right side of
the VMH, ARC, DMH, or PVH or into the lateral ventricle according to the atlas
of Franklin and Paxinos (26). The stereotaxic coordinates were AP 1.3 (1.3
mm anterior to the bregma), L 0.3 (0.3 mm lateral to the bregma), and H 5.8
(5.8 mm below the bregma on the surface of the skull) for the VMH; AP 1.6, L
0.2, and H 6.1 for the ARC; AP 1.6, L 0.3, and H 5.5 for the DMH; AP 0.75, L 0.2,
and H 4.9 for the PVH; and AP 0.3, L 1.0, and H 2.25 for the lateral ventricle.
Cannulas were anchored ﬁrmly to the skull. In experiments featuring admin-
istration of the MCR antagonist SHU9119, cannulas were implanted both into
VMH and intracerebroventricularly.
Three days before determination of tissue glucose uptake, a silicone
catheter was implanted into the external jugular vein. Animals were handled
repeatedly during the recovery period (2 weeks) after cannula implantation to
habituate them to the injection and blood-sampling procedures. Correct
placement of the cannula tips was veriﬁed microscopically in brain sections in
all experiments, with 90% of animals manifesting correct placement. Ty-
rosine phosphorylation of signal transducer and activator of transcription 3
(STAT3) in each medial hypothalamic nucleus was examined after injection of
leptin, as described below. Food was removed just before the administration
of the agents. All animal experiments were performed in accordance with
institutional guidelines for the care and handling of experimental animals, and
they were approved by the ethics committee for animal experiments of the
National Institute for Physiological Sciences.
Administration of leptin, MT-II, and SHU9119. Leptin (5 ng) (National
Hormones and Pituitary Program, Torrance, CA) or MT-II (10 ng) (Phoenix
Pharmaceuticals, Burlingame, CA) dissolved in 0.1 l physiological saline was
injected with the use of a Hamilton microsyringe into the right side of the
VMH, DMH, PVH, or ARC of freely moving mice through the unilateral cannula
implanted into the corresponding nucleus. The concentrations of leptin (3
mol/l) and MT-II (100 mol/l) dissolved in 0.1 l physiological saline injected
into the medial hypothalamic nuclei are at least 10 times higher than those
necessary for the maximum activation of leptin receptor and MCRs (27–29).
Alternatively, MT-II (3 g) in 0.5 l saline was injected into the lateral
ventricle. SHU9119 (1 g) (Phoenix Pharmaceuticals) in 0.5 l saline was also
injected intracerebroventricularly immediately before leptin injection. The
dose of MT-II and SHU9119 injected intracerebroventricularly altered food
intake signiﬁcantly (30,31). Control animals received 0.1 l saline delivered
into the various nuclei or 0.5 l saline delivered intracerebroventricularly,
respectively.
Measurement of the rate constant of 2-[
3H]deoxy-D-glucose uptake in
peripheral tissues. The rate constant of net tissue uptake of 2-[
3H]deoxy-D-
glucose (2[
3H]DG) in peripheral tissues was determined, as described previ-
ously (32,33), by injecting a mixture of 6.25 Ci 2[
3H]DG (10 Ci/mmol) and
1.25 Ci [
14C]sucrose (10 Ci/mmol) (American Radiolabeled Chemicals, St.
Louis, MO) through the jugular vein catheter 3 or 6 h after the microinjection
of leptin or MT-II. Blood was collected 0, 10, 15, and 20 min after injection of
the radioactive tracers. Immediately after collection of the ﬁnal blood sample
(20 min), an overdose of pentobarbital sodium (100 mg/kg) was injected
through the jugular vein catheter and the mice were rapidly decapitated.
Hypothalamic nuclei were then rapidly dissected as described below and
frozen in liquid nitrogen for subsequent immunoblot analysis. Skeletal muscle
(soleus, red and white portions of the gastrocnemius, and extensor digitorum
longus [EDL]) as well as interscapular BAT, heart, spleen, and epididymal
white adipose tissue (WAT) were rapidly dissected, weighed, and assayed for
the radioactivity. Plasma samples were also analyzed for glucose (Glucose CII
Test; Wako, Osaka, Japan) and insulin (mouse insulin ELISA kit [U-Type];
Shibayagi, Gunma, Japan) concentrations. The rate constant of net tissue
uptake of 2[
3H]DG was calculated as described previously (32,33). The
radioactivity of [
14C]sucrose in tissues was used to calculate the 2[
3H]DG
radioactivity remaining in the extracellular space (33).
Sampling of medial hypothalamic nuclei. Medial hypothalamic nuclei were
isolated as described previously (34). The accuracy of the dissection was
assessed by measurement of mRNAs for neuropeptides or transcription
factors such as corticotropin-releasing factor (CRF) mRNA for the PVH,
POMC and NPY mRNAs for the ARC, SF1 mRNA for the VMH, and the absence
of these various mRNAs for the DMH. The right side of the PVH, ARC, VMH,
or DMH was dissected from a 1-mm-thick sagittal section prepared from the
midline of the fresh brain (online appendix supplemental Fig. 1 [available at
http://diabetes.diabetesjournals.org/cgi/content/full/db09-0638/DC1]).
Immunoblot analysis. Hypothalamic nuclei were homogenized at 4°C in PBS
containing 1% Nonidet P-40. The homogenates were centrifuged, and the
resulting supernatants (5 g of protein) were fractionated by SDS-PAGE.
Immunoblot analysis was then performed with antibodies (1 g/ml), including
those to the Tyr
705-phosphorylated or total forms of STAT3 (Cell Signaling
Technology, Danvers, MA), to c-Fos (Santa Cruz Biotechnology, Santa Cruz,
CA), or to -actin (Cell Signaling Technology). Immune complexes were
visualized with horseradish peroxidase–conjugated secondary antibodies
(Santa Cruz Biotechnology) and enhanced chemiluminescence reagents (GE
Healthcare, Tokyo, Japan). Protein bands were quantiﬁed using Image J
software (National Institutes of Health, http://rsbweb.nih.gov/ij).
RNA extraction, RT-PCR analysis, and quantitative real-time PCR.
Total RNA was isolated from hypothalamic and peripheral tissue with the use
of Isogen (Nippon Gene, Wako, Japan), and portions of the RNA (300 ng) were
subjected to reverse transcription with an oligo(dT) primer and avian myelo-
blastosis virus reverse transcriptase (Takara, Shiga, Japan). The resulting
cDNA was subjected to the PCR with LA Taq (Takara) and primers obtained
from Sigma Genosys (Ishikari, Japan). For quantitative real-time PCR, cDNA
was ampliﬁed using SYBR Green PCR Master Mix with an ABI 7500 real-time
PCR system (Applied Biosystems, Tokyo, Japan). Data were normalized by the
amount of eukaryotic elongation factor 2 (eEF2) mRNA. The sequences of the
primers are shown in supplemental Table 1.
Statistical analysis. Data are presented as means  SE. Statistical analysis
of STAT3 phosphorylation, c-Fos expression, and real-time PCR was per-
formed by Student t test, and analysis for other experiments was performed by
ANOVA followed by Dunnett test. A P value of 0.05 was considered
statistically signiﬁcant.
RESULTS
Effects of leptin injection into medial hypothalamic
nuclei on glucose uptake in peripheral tissues. Micro-
injection of leptin (5 ng) into the VMH induced a signiﬁ-
cant increase in the rate constant of 2[
3H]DG uptake in the
red type of skeletal muscle (soleus and red portion of
gastrocnemius), mixed type of skeletal muscle (EDL),
BAT, and heart but not in spleen or epididymal WAT (Fig.
1). Glucose uptake in red or mixed skeletal muscle was
signiﬁcantly increased at 6 h after leptin injection (Fig.
1A), whereas that in BAT and heart was increased at both
3 and 6 h (Fig. 1B). Glucose uptake in the white portion of
the gastrocnemius showed a tendency to increase in
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signiﬁcant. Glucose uptake in peripheral tissues at 3 h
after saline injection into the VMH did not differ from that
apparent at 6 h (data not shown). Injection of leptin into
the VMH signiﬁcantly increased GLUT4 mRNA in BAT and
heart but not in soleus muscle at 6 h after leptin injection
(Fig. 1E). It also increased uncoupling protein 1 (UCP1)
mRNA in BAT. Hexokinase II mRNA did not change in
soleus, BAT, or heart (Fig. 1E).
Injection of maximal dose of leptin into the ARC in-
duced a small but signiﬁcant increase in the rate constant
of 2[
3H]DG uptake in BAT at 6 h after injection, but it had
no effect on glucose uptake in skeletal muscle, heart,
spleen, or WAT (Fig. 2). Injection of leptin into the DMH or
PVH had no effect on glucose uptake in peripheral tissues
(Fig. 2). Glucose uptake in peripheral tissues after saline
injection into the DMH or PVH did not differ from that
apparent after saline injection into the ARC (data not
shown). Plasma glucose and insulin concentrations were
not affected by leptin injection into the VMH or other
hypothalamic nuclei (supplemental Table 2), consistent
with previous observations (13,15).
To determine whether leptin activated Ob-Rb in the
hypothalamic nuclei, we examined the tyrosine phosphor-
ylation of STAT3 in tissue samples therefrom. RT-PCR
analysis conﬁrmed that the isolated PVH, ARC, and VMH
specimens were enriched in CRF mRNA, POMC and NPY
mRNAs, and SF1 mRNA, respectively, and that the DMH
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FIG. 1. Effects of leptin injection into the VMH on glucose uptake and gene expression in peripheral tissues. The rate constant of 2[
3H]DG uptake
was measured in skeletal muscle (A), BAT and heart (B), spleen (C), and epididymal WAT (D) at 3 and 6 h after injection of leptin or saline
(control) into the VMH of mice. , Saline VMH (6 h); p, leptin VMH (3 h); f, leptin VMH (6 h). E: The mRNA levels of GLUT4, hexokinase II
(HKII), and UCP1 in soleus, BAT, and heart were quantiﬁed by real-time PCR. Values are normalized by the level of eEF2 mRNA. Gastro-R, red
portion of gastrocnemius; Gastro-W, white portion of gastrocnemius. Data are means  SE for four to seven mice. *P < 0.05 vs. the corresponding
value for saline-injected controls. , Saline VMH (6 h); f, leptin VMH (6 h).
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hypothalamic nuclei were thus accurately dissected. Mi-
croinjection of leptin into the VMH, DMH, or PVH prefer-
entially increased the tyrosine phosphorylation of STAT3
to the similar extent in the corresponding nucleus at 6 h
after injection (Fig. 3B–D). These results conﬁrmed that
leptin was correctly injected into these various hypotha-
lamic nuclei. Injection of leptin into the ARC increased the
tyrosine phosphorylation of STAT3 in the DMH as well as
in the ARC (Fig. 3E), possibly as a result of leakage of
leptin into the DMH through the surface of the injection
cannula, given that the ARC cannula passed through the
DMH. Together, these results suggested that the VMH is a
key target of leptin in its regulation of glucose uptake in
skeletal muscle, heart, and BAT, whereas the leptin recep-
tor in the ARC mediates stimulation of glucose uptake
in BAT.
We next examined whether leptin injection into the
VMH might increase neuronal activity in other hypotha-
lamic nuclei by measuring expression of the transcription
factor c-Fos. Leptin injection into the VMH signiﬁcantly
increased c-Fos expression in the ARC as well as in the
VMH at 6 h after injection (Fig. 3F). Leptin injection into
the VMH increased the phosphorylation of STAT3 in the
nucleus preferentially at 1 h after the injection, similar to
that at 6 h. However, it did not increase c-Fos expression
in any nucleus at 1 h (supplemental Fig. 2), as described
previously (35). Leptin injection into the VMH did not
increase POMC mRNA in the ARC at 6 h after injection
(supplemental Fig. 2).
Effect of intracerebroventricular injection of an
MCR antagonist on glucose uptake in peripheral
tissues induced by injection of leptin into the VMH.
We next examined the role of MCRs in glucose uptake in
peripheral tissues induced by injection of leptin into the
VMH (Fig. 4). Injection of the MCR antagonist SHU9119 (1
g) into the lateral ventricle (intracerebroventricularly)
abolished the increase in 2[
3H]DG uptake in peripheral
tissues normally apparent at 6 h after the injection of
leptin into the VMH. Injection of SHU9119 alone did not
affect glucose uptake in peripheral tissues. Plasma glucose
and insulin levels were also not changed in response to
intracerebroventricular injection of SHU9119 (supplemen-
tal Table 2).
Effects of intracerebroventricular injection of an
MCR agonist on glucose uptake in peripheral tissues.
We tested the effects of intracerebroventricular injection
of the MCR agonist MT-II on glucose uptake in peripheral
tissues (Fig. 5). The intracerebroventricular injection of
MT-II (3 g) increased 2[
3H]DG uptake in BAT, heart, and
all types of skeletal muscle, including the white portion of
the gastrocnemius, but not in spleen or epididymal WAT,
at 3 or 6 h after injection. Glucose uptake in peripheral
tissues at 3 h after saline injection did not differ from that
apparent at 6 h (data not shown). The intracerebroventric-
ular injection of MT-II increased the plasma glucose level
at both 3 and 6 h after injection (supplemental Table 2).
These results thus suggested that intracerebroventricular
injection of MT-II promotes glucose production as well as
glucose uptake in certain peripheral tissues. In contrast,
plasma insulin concentration did not change after intrace-
rebroventricular injection of MT-II, despite the associated
hyperglycemia, suggesting that MT-II inhibits insulin se-
cretion from pancreatic -cells.
Effects of MT-II injected into medial hypothalamic
nuclei on glucose uptake in peripheral tissues. Finally,
we examined the effects of direct injection of MT-II into
the individual medial hypothalamic nuclei on glucose
uptake in peripheral tissues (Fig. 6). Microinjection of
MT-II (10 ng) into the VMH increased 2[
3H]DG uptake in
BAT, heart, and all types of skeletal muscle but not in
spleen or epididymal WAT. In contrast, injection of MT-II
into the PVH increased glucose uptake only in BAT, and
that into the DMH or ARC did not affect glucose uptake in
any of the peripheral tissues examined. Plasma glucose
and insulin levels did not change in response to injection
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FIG. 2. Effects of leptin injection into the ARC, DMH, or PVH on
glucose uptake in peripheral tissues. The rate constant of 2[
3H]DG
uptake was measured in skeletal muscle (A), BAT and heart (B),
spleen (C), and epididymal WAT (D) at 6 h after injection of leptin into
the hypothalamic nuclei of mice. Results obtained after injection of
saline into the ARC are shown as a control. Data are means  SE for six
or seven mice. *P < 0.05 vs. the corresponding value for control
animals injected with saline into ARC. , Saline ARC; f, leptin ARC; p
leptin DMH; µ, leptin PVH.
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Table 2).
DISCUSSION
Leptin is a physiologically and clinically important hor-
mone that regulates glucose metabolism in peripheral
tissues. We have previously shown that microinjection of
leptin into the VMH and nearby medial hypothalamic area
preferentially increased glucose uptake in skeletal muscle,
heart, and BAT (14–16). In the present study, we found
that activation of the leptin receptor speciﬁcally in the
VMH, as detected by measurement of the tyrosine phos-
phorylation of STAT3, resulted in a marked increase in
glucose uptake in those peripheral tissues, similar to the
effects of intracerebroventricular or peripheral administra-
tion of leptin (13,36). In contrast, injection of leptin into
the ARC increased glucose uptake only in BAT. Injection
of leptin into the DMH or PVH had no effect on glucose
uptake in any of the peripheral tissues examined. The
present data thus suggest that the leptin receptor in the
VMH and ARC regulates glucose uptake in different pe-
ripheral tissues.
Our present results further indicate that MCR activation
is necessary for the increase in glucose uptake in periph-
eral tissues induced by injection of leptin into the VMH.
The intracerebroventricular injection of SHU9119 thus
abolished the effect of leptin injected into the VMH on
peripheral glucose uptake, whereas intracerebroventricu-
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FIG. 3. Effects of leptin injection into medial hypothalamic nuclei on tyrosine phosphorylation of STAT3 and c-Fos expression. A: RT-PCR analysis
of CRF, POMC, NPY, SF1, and eEF2 (loading control) mRNAs in the PVH, ARC, VMH, and DMH. Data are from two animals in a representative
experiment. B–E: Immunoblot analysis of the phosphorylation of STAT3 on Tyr
705 in the medial hypothalamic nuclei at 6 h after leptin injection
into the VMH (B), DMH (C), PVH (D), or ARC (E). Leptin was injected into the right side of the hypothalamic nuclei, and the same side of the
PVH (P), ARC (A), VMH (V), and DMH (D) was collected. Injection of saline into the VMH was used as a control. Figure shows separate saline
controls for each nucleus. Representative blots of Tyr
705-phosphorylated STAT3 are shown in the upper panels, and quantitative data (means 
SE) from four to six mice are shown in the lower panels. The amount of Tyr
705-phosphorylated STAT3 was normalized by that of total STAT3,
and the normalized values were expressed relative to the corresponding value for the PVH of control mice. *P < 0.05 for the indicated
comparisons. F: Immunoblot analysis of c-Fos expression in the medial hypothalamic nuclei after leptin injection into the VMH. The right side of
the PVH, ARC, VMH, and DMH was collected at 6 h after injection of leptin or saline into the same side of the VMH. A representative blot is shown
in the upper panel, and quantitative data (means  SE) from four to six mice are shown in the lower panel. The amount of c-Fos was normalized
by that of -actin, and the normalized values were expressed relative to the corresponding value for the saline-injected control mice. *P < 0.05.
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eral tissues. Moreover, injection of MT-II into VMH, but not
that into the DMH or ARC, increased glucose uptake in
skeletal muscle, heart, and BAT, whereas injection of
MT-II into the PVH increased glucose uptake preferentially
in BAT. The VMH expresses abundantly MC3R as well as
MC4R (23,25). Both MCRs in the VMH and PVH may play
an important role in the regulation of glucose uptake in
peripheral tissues.
POMC neurons in the ARC receive strong excitatory
input from the dorsomedial region of the VMH (37). The
restoration of Ob-Rb expression in the VMH by adeno-
associated virus–mediated gene transfer in Koletsky rats
increased the amount of POMC mRNA in the ARC (20). We
have now shown that injection of leptin into the VMH
increased c-Fos expression in the ARC without an effect
on STAT3 phosphorylation in the ARC. Furthermore, the
effect of leptin injected into the VMH on glucose uptake in
peripheral tissues was found to be dependent on MCRs in
the brain. We therefore propose that stimulation of VMH
neurons by leptin results in activation of a set of POMC
neurons in the ARC and thereby increases glucose uptake
in skeletal muscle, heart, and BAT. MCRs in the VMH and
PVH contribute to the upregulation of glucose uptake in
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FIG. 4. Effect of intracerebroventricular injection of SHU9119 on
glucose uptake in peripheral tissues induced by injection of leptin into
the VMH. The rate constant of 2[
3H]DG uptake in skeletal muscle (A),
BAT and heart (B), spleen (C), and epididymal WAT (D) was measured
6 h after injection of leptin or saline (control) into the VMH. The effect
of SHU9119 was determined by intracerebroventricular injection im-
mediately before injection of leptin. Data are means  SE for six or
seven mice. *P < 0.05 vs. the corresponding value for saline-injected
control animals. , Saline VMH; p, SHU9119 i.c.v.; f, leptin VMH; µ,
leptin VMH  SHU9119 i.c.v.
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FIG. 5. Effects of intracerebroventricular injection of MT-II on
glucose uptake in peripheral tissues. The rate constant of 2[
3H]DG
uptake in skeletal muscle (A), BAT and heart (B), spleen (C), and
epididymal WAT (D) was measured at 3 or 6 h after intracerebroven-
tricular injection of MT-II or saline (control). Data are means  SE
for six or seven mice. *P < 0.05 vs. the corresponding value for
saline-injected control animals. , Saline i.c.v. (6 h); p, MT-II i.c.v.
(3 h); f, MT-II i.c.v. (6 h).
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VMH. Although c-Fos expression did not increase in the
PVH in response to leptin injection into the VMH, this may
have been due to the operation of -aminobutyric acid
(GABA)-mediated neurotransmission in the PVH (6). The
mechanism by which injection of leptin into the ARC
increased glucose uptake speciﬁcally in BAT remains
unclear. One possible explanation for this observation is
that the injection of leptin into the ARC activated a
selective set of POMC neurons in the ARC that regulate
glucose uptake in BAT alone, with POMC neurons being
abundant in both the anterior and posterior regions of the
ARC (38). It is also possible that POMC neurons in the
ARC that regulate glucose uptake in skeletal muscle and
heart require excitatory input as well as leptin for their full
activation.
The intracerebroventricular injection of MT-II increased
glucose uptake in BAT to a markedly greater extent than
did the maximum dose of injection of MT-II into the VMH
or PVH. MC4R-expressing neurons in several regions of
the brain stem as well as in the hypothalamic nuclei
connect polysynaptically with interscapular BAT (39).
Direct injection of MT-II into the raphe pallidus induces a
thermogenic response in interscapular BAT (40). Glucose
uptake in BAT might thus be regulated by MCRs in
multiple brain regions. To date, there is little histological
evidence of a connection between VMH neurons and
interscapular BAT, although injection of leptin into the
VMH increases plasma catecholamine levels more effec-
tively than does that into other hypothalamic regions (41).
We previously showed that injection of leptin into the
medial hypothalamus increased glucose uptake in periph-
eral tissues through the activation of sympathetic nerves
(14,15). Injection of leptin into the medial hypothalamus
also increased insulin sensitivity in peripheral tissues by a
-adrenergic mechanism (14). Whereas the molecular
mechanism remains elusive, a direct effect of -adrenergic
receptors expressed in peripheral tissues as well as a
-adrenergic receptor–dependent increase in blood ﬂow
appear to contribute to leptin-induced glucose uptake in
these tissues.
The DMH is an important hypothalamic nucleus in the
regulation of thermogenesis in BAT (42). Injection of a
GABA typeA (GABAA) receptor antagonist into the DMH
thus increased thermogenic activity in BAT (42). More-
over, injection of a GABAA receptor agonist into the DMH
blocked sympathetic, thermogenic, and cardiovascular
responses induced either by injection of prostaglandin E2
into the medial preoptic area (43) or by skin cooling (44).
Both Ob-Rb and MC4R are abundant in the DMH (7).
Furthermore, DMH neurons, including those expressing
MC4R, connect polysynaptically with interscapular BAT
(39). However, we have now shown that injection of leptin
or MT-II into the DMH did not increase glucose uptake in
the peripheral tissues examined. Although we cannot
exclude the possibility that injection of leptin or MT-II
activated only a subset of DMH neurons expressing Ob-Rb
or MCR, our results suggest that the leptin receptor and
MCR in the DMH have other roles, such as the regulation
of food intake or modulation of BAT thermogenesis in
response to cold stimuli.
Skeletal muscle is a central player in glucose homeosta-
sis in mammals. Our present results indicate that the VMH
regulates glucose uptake in skeletal muscle as well as in
heart and BAT, accompanying increased GLUT4 mRNA in
BAT and heart. Thus, increased expression of GLUT4 may
involve the acute increase in glucose uptake in BAT and
heart in response to leptin, while other mechanism might
be involved in the leptin-induced glucose uptake in skele-
tal muscle. Intracerebroventricular injection of MT-II has
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FIG. 6. Effects of MT-II injection into VMH, PVH, DMH, or ARC on glucose uptake in peripheral tissues. The rate constant of 2[
3H]DG uptake in
skeletal muscle (A), BAT and heart (B), spleen (C), and epididymal WAT (D) was measured at 6 h after the injection of MT-II into the individual
hypothalamic nuclei. Injection of saline into VMH was used as a control. Data are means  SEM for six or seven mice. *P < 0.05 vs. the
corresponding value for saline-injected control animals. , VMH; f, MT-II VMH; p, MT-II PVH; j, MT-II DMH; µ, MT-II ARC.
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skeletal muscle at 24 h after the injection (22). Gene
expression in skeletal muscle in response to leptin and
MT-II may require 24 h.
The present results showed that injection of leptin or
MT-II in some medial hypothalamic nuclei increased glu-
cose uptake in certain peripheral tissues, while it did not
alter plasma glucose level. These results suggest that
leptin and MT-II stimulates hepatic glucose production as
well as glucose utilization in peripheral tissues. The result
was supported by the previous report (13) showing that
leptin increased plasma glucose turnover in mice at 6 h
after the injection. Moreover, Gutierrez-Juarez et al. (45)
has shown that intracerebroventricular infusion of MCR
agonist increased hepatic glucose production in lean rats
at 6 h after the start of the infusion, while it inhibited
hepatic glucose production at 7 days (46). These results
suggest that the effects of leptin and melanocortin recep-
tor agonist on hepatic glucose production alter time
dependently.
Recent study suggests that MT-II seems to be a promis-
ing agent to bypass leptin resistance and to improve
energy homeostasis in diet-induced obese mice (47). We
have shown that intracerebroventricular injection of MT-II
but not leptin activates AMP-activated protein kinase in
skeletal muscle in diet-induced obese mice (48). The PVH
and VMH may be target sites of MT-II to improve glucose
metabolism in these mice.
Together, our results suggest that the VMH plays a key
role in leptin- and MT-II–induced glucose uptake in skele-
tal muscle, heart, and BAT, whereas the leptin receptor in
the ARC and MCRs in the PVH regulate glucose uptake in
BAT. The medial hypothalamic nuclei thus appear to play
distinct roles in the regulation of glucose uptake in periph-
eral tissues by leptin and MT-II.
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